Public market insider buying at Invictus MD Strategies (GENE)

Public market insider buying at Invictus MD Strategies (V:GENE)

Brenda Mae Dixon, a Subsidiary Executive, acquired 128,000 Common Shares on a direct ownership basis at prices ranging from $1.200 to $1.376 between October 22nd and 26th, 2018. This represents a $165,862 investment into the company's shares and an account share holdings change of 1.5%.

Invictus MD Strategies is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Invictus MD Strategies Corp is Canada-based company engaged in the field of alternative medicine. The Company is focused on two main verticals within the Canadian cannabis sector: Licensed Producers and AB Laboratories Inc. The Licensed Producers vertical, which is under the Access to Cannabis for Medical Purposes (ACMPR), comprises investment in Acreage Pharms Ltd, located in West-Central Alberta; AB Laboratories Inc vertical comprises investment in AB Laboratories Inc, located near Hamilton, Ontario, which has both its cultivation and sales license under ACMPR. Also, the Company is a main shareholder for Future Harvest Development Ltd, a fertilizer and nutrients manufacturer based in Kelowna, British Columbia.